基于半直接靶向的立体定向中脑毁损术治疗难治性疼痛病例系列
该回顾性病例系列纳入2014至2021年间22例药物难治性疼痛患者,接受单侧立体定向中脑毁损术(17例)或联合双侧前扣带回毁损术(5例)。术后3个月86.3%、12个月76.9%的患者获优良效果(疼痛改善>50%),平均疼痛缓解3个月为80.1%、12个月为71.4%;手术失败率与复发率均为9.1%,并发症率8%,无死亡。
要点
- MR引导半直接靶向中脑毁损术对药物难治性疼痛有效且风险相对较低。
- 上肢、颈臂及面部疼痛疗效优于躯干疼痛,神经病理性合并躯干疼痛效果最差。
- 毁损温度75°C可能减少复发,但并发症风险增加。
核心结论
- 当代立体定向中脑毁损术是治疗药物难治性疼痛有效、风险相对较低且可能应用不足的手段。
研究设计与样本
- 回顾性研究,复习2014至2021年作者所在机构22例难治性疼痛患者的病历资料。
- 疼痛类型:伤害性5例、神经病理性10例、混合性7例;单侧中脑毁损术17例,联合双侧前扣带回毁损术5例。
- 采用95%置信区间。
主要发现
- 患者12女10男,年龄23至80岁(平均55.1±17.1岁)。
- 术后3个月86.3%、12个月76.9%的患者获优良效果(疼痛改善>50%),平均疼痛缓解3个月80.1%、12个月71.4%。
- 联合双侧前扣带回毁损术未改善结果;上肢、颈臂及面部疼痛显著优于躯干疼痛。
- 手术失败(疼痛缓解≤25%)与复发率均为9.1%,似与较低毁损参数(70°C/60秒)及神经病理性/躯干疼痛相关。
- 并发症率8%(垂直复视、意识模糊/躁动),均见于75°C/60秒毁损患者;无死亡。
关键数值与推荐
- 射频热凝参数为70°C-75°C/60秒。
- 优良效果定义为疼痛改善>50%,手术失败定义为疼痛缓解≤25%。
- 巨刺激最常见反应为中枢性热感/中度不适。
- 靶点包括脊髓网状丘脑束(神经病理性/混合性疼痛17例)、三叉丘脑束(面部伤害性/混合性疼痛5例)、新脊髓丘脑束(躯体伤害性/混合性疼痛7例)。
临床怎么用
- 对药物难治性疼痛可考虑立体定向中脑毁损术,术前需半直接法仔细确定靶点坐标并重视电刺激巨刺激反应。
- 面部、上肢及颈臂疼痛患者可能获益更明显,神经病理性合并躯干疼痛者疗效较差。
- 提高毁损温度至75°C可能减少复发,但需权衡并发症风险。
局限性
- 为回顾性病例系列,样本量较小(22例),未设对照组。
- 手术失败与复发相关因素为观察性关联,未做统计学推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: One of the few resources for treating medically intractable pain is ablative surgery, but its indications have fallen dramatically over the last decades. One such procedure is mesencephalotomy. This study aims to determine current risks and benefits of MR-guided semidirect targeting-based stereotactic mesencephalotomy. METHODS: This was a retrospective study based on a review of the medical records of 22 patients with nociceptive (n = 5), neuropathic (n = 10), or mixed (n = 7) refractory pain treated with unilateral mesencephalotomy alone (17 patients) or associated with bilateral anterior cingulotomy (5 patients) between 2014 and 2021 in the authors' institutions. The confidence interval adopted in this study was 95%. RESULTS: The sample included 12 women and 10 men with ages ranging from 23 to 80 years (mean 55.1 ± 17.1 years). Using MR-guided semidirect targeting, the following structures were targeted: spinoreticulothalamic (neuropathic/mixed pain, n = 17), trigeminothalamic (nociceptive/mixed pain in the face, n = 5), and neospinothalamic (nociceptive/mixed pain in the body, n = 7) pathways. The most common response to macrostimulation was central heat/moderate discomfort. Radiofrequency thermocoagulation was made with 70°C-75°C/60 sec. A total of 86.3% (3 months) and 76.9% (12 months) of the patients achieved excellent or good results (improvement of pain > 50%), presenting with a significant mean pain relief of 80.1% at 3 months and 71.4% at 12 months postoperatively. The addition of bilateral anterior cingulotomy did not improve the results. Patients with upper limb, cervicobrachial, and face pain did significantly better than those with trunk pain. The worst results were seen in patients with neuropathic and/or trunk pain. The surgical failure (pain relief ≤ 25%) and recurrence rates were 9.1% each, apparently related to the use of lower lesioning parameters (70°C/60 sec) and to the presence of neuropathic and/or trunk pain. The morbidity rate was 8%, with both complications (vertical diplopia and confusion/agitation) happening in patients lesioned with 75°C/60 sec. There were no deaths in this series. CONCLUSIONS: These results show that contemporary stereotactic mesencephalotomy is an effective, relatively low-risk, and probably underused procedure for treating medically intractable pain. Careful semidirect determination of the target coordinates associated with close attention to electrical macrostimulation responses certainly plays an important role in avoiding complications in most of the procedures. A higher lesioning temperature (75°C) apparently prevents recurrence, but at the cost of an increased risk of complications.
引用
- Marques RAS, Alencar HS, Bannach MA, et al. Semidirect targeting-based stereotactic mesencephalotomy for the treatment of refractory pain: a case series. J Neurosurg. 2021. PMID: 34678784. doi:10.3171/2021.6.JNS21709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。